SCHEMBL27875615

SCHEMBL27875615

O=C(Cc1ccc(-c2cc[c]cc2)cc1)Nc1ccccc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.79
KMT2A Q03164 3/20 0.79
EPHX2 P34913 1/20 0.67
RORC P51449 1/20 0.57
RET P07949 1/20 0.54
WNT3A P56704 1/20 0.53
ROCK2 O75116 1/20 0.53
ROCK1 Q13464 1/20 0.53
BCHE P06276 1/20 0.52
ACHE P22303 1/20 0.52
PRMT1 Q99873 1/20 0.51
SLC6A2 P23975 1/20 0.51
SLC6A3 Q01959 1/20 0.51
HDAC3 O15379 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4803134 0.94 MEN1 (0.69) MEN1KMT2AEPHX2RORCWNT3A
SCHEMBL1283623 0.94 KMT2A (0.79) MEN1KMT2AEPHX2RORCRET
SCHEMBL28043487 0.90 EPHX2 (0.76) MEN1KMT2AEPHX2BCHEACHE
SCHEMBL3714852 0.89 KMT2A (1.00) MEN1KMT2AEPHX2RORCRET
SCHEMBL694917 0.87 EPHX2 (0.76) MEN1KMT2AEPHX2BCHEACHE
SCHEMBL10054999 0.85 EPHX2 (0.92) MEN1KMT2AEPHX2BCHEACHE
SCHEMBL1516167 0.81 EPHX2 (1.00) MEN1KMT2AEPHX2BCHEACHE
SCHEMBL1948079 0.80 KMT2A (0.83) MEN1KMT2AEPHX2RORCWNT3A
SCHEMBL4802418 0.80 MEN1 (0.66) MEN1KMT2AEPHX2RORCWNT3A
Hydrochloric Acid SCHEMBL27735879 0.79 EPHX2 (0.96) MEN1KMT2AEPHX2BCHEACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102750459-A Anti-HPV (human papillomavirus) medicine virtual screening method by using DNA helicase E1 of HPV as target point UNIV LIAONING 2012-10-24 CN disclosed